Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Onychomycosis Companies

Companies that focus on onychomycosis, a fungal infection of the nails, are often involved in the development, manufacturing, and distribution of treatments and products aimed at addressing this condition. Onychomycosis, commonly known as toenail or fingernail fungus, can be a persistent and challenging issue, and these companies aim to provide effective solutions.

Onychomycosis Key Companies Latest Onychomycosis Companies Update

Apr 2023: Leading pharmaceutical company Cipla said it has signed a license agreement with Novartis Pharma AG to produce and distribute the Galvus brand, used to treat type 2 diabetes, starting January 1, 2026. According to a regulatory filing, the Mumbai-based business and Novartis Pharma AG have inked a permanent license deal for producing and marketing the Galvus and Galvus combo brands. According to the pharmaceutical company, Galvus is one of the top brands in the Dipeptidyl Peptidase-4 (DPP4) market and a well-known brand in the oral diabetes medicine sector.

Aug 2023: Today, its strategic partner, Kaken Pharmaceutical Co. Ltd., launched NexoBrid® in Japan to manage deep partial and full-thickness burns in adults and pediatric patients. MediWound Ltd. is a fully integrated biopharmaceutical business dedicated to developing next-generation enzymatic therapeutics for tissue repair. The exclusive rights to market and dispense NexoBrid in Japan belong to Kaken Pharmaceutical, a well-regarded pharmaceutical firm in Japan. For handling deep partial and full-thickness thermal burns, NexoBrid is recommended for eschar eradication. The present standard of care is based mostly on costly, non-selective surgical excisions that may result in deformity.

List of Onychomycosis Key companies in the market

Novartis AG (Switzerland)

Pfizer, Inc. (the US)

Galderma Laboratories (Switzerland)

Bausch Health Sciences (Canada)

Moberg Pharma AB (Sweden)

Reddy’s Laboratories Ltd (India)

Medimetriks Pharmaceuticals, Inc. (US)

Merz Pharma (Germany)

Kaken Pharmaceutical Co., Ltd (Japan)

Johnson & Johnson Services, Inc. (US)

GlaxoSmithKline plc (UK)

Taro Pharmaceuticals Industries Ltd (Israel)

Onychomycosis Market Highlights:

Onychomycosis Market Size

Onychomycosis Market Trends

Onychomycosis Market Analysis

Onychomycosis Market Share

Onychomycosis Market Highlights:

Onychomycosis Market Trends

Onychomycosis Market Analysis

Onychomycosis Market Share

Onychomycosis Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.